Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

Agenus Inc. (AGEN)

-NasdaqCM
7.26 Up 0.35(5.07%) Aug 28, 4:00PM EDT
|After Hours : 7.26 0.00 (0.00%) Aug 28, 4:29PM EDT
Add to Portfolio
Prev Close:6.91
Open:6.99
Bid:5.75 x 300
Ask:8.46 x 400
1y Target Est:13.40
Beta:-0.512956
Next Earnings Date:N/A
Day's Range:6.87 - 7.28
52wk Range:2.56 - 10.16
Volume:940,199
Avg Vol (3m):1,554,210
Market Cap:612.07M
P/E (ttm):N/A
EPS (ttm):-1.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENUp 5.07%612.07M
ABPIDown 20.00%287.22k

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):43.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.06
Quarterly EPS Est (Sep-15) :-0.11
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback